Current Medicinal Chemistry

Sickle Cell Anemia and Antisickling Agents Then and Now
pp. 79-88(10)
Author: Mehanna A.S.

Current Trends in the Development of New Antidepressants
pp. 89-100(12)
Authors: Pacher P.; Kohegyi E.; Kecskemeti V.; Furst S.

Perspectives on Factor Xa Inhibition
pp. 101-119(19)
Authors: Rai R.; Sprengeler P.A.; Elrod K.C.; Young W.B.

Syntheses and Antitumor Activities of Potent Inhibitors of Ribonucleotide Reductase 3-Amino-4-Methylpyridine-2-Carboxaldehyde-Thiosemicarba-zone (3-Amp), 3-Amino-Pyridine-2-Carboxaldehyde-Thiosemicarbazone (3-Ap) and its Water-Soluble Prodrugs
pp. 121-133(13)
Authors: Li J.; Zheng L.; King I.; Doyle T.W.; Chen S.H.

Biological Properties of Citrus Flavonoids Pertaining to Cancer and Inflammation
pp. 135-153(19)
Authors: Manthey J.A.; Guthrie N.; Grohmann K.

AMPA Receptor Antagonists
pp. 155-170(16)
Authors: Nikam S.S.; Kornberg B.E.

Heme Aggregation Inhibitors Antimalarial Drugs Targeting an Essential Biomineralization Process
pp. 171-189(19)
Authors: Ziegler J.; Linck R.; Wright D.W.

Recent Advances in the Discovery of Protein Kinase C Modulators Based on the Structures of Natural Protein Kinase C Activators
pp. 191-202(12)
Author: Ma D.

The Discovery of the Potent and Selective Antitumour Agent 2-(4-Amino-3-methylphenyl) benzothiazole (DF 203) and Related Compounds
pp. 203-210(8)
Authors: Bradshaw T.D.; Stevens M.F.G.; Westwell A.D.

Histone Deacetylase: A Target for Antiproliferative and Antiprotozoal Agents
pp. 211-235(25)
Authors: Meinke P.T.; Liberator P.